The human insulin analog insulin lispro improves insulin binding on circulating monocytes of intensively treated insulin-dependent diabetes mellitus patients.

Jehle, P M; Fussgaenger, R D; Kunze, U; Dolderer, M; Warchol, W; Koop, I

Jehle, P M; Fussgaenger, R D; Kunze, U; Dolderer, M; Warchol, W; Koop, I.

Affiliation

Jehle PM; Department of Internal Medicine, University of Ulm, Germany.

J Clin Endocrinol Metab ; 81(6): 2319-27, 1996 Jun.

Article in En | MEDLINE | ID: mdl-8964871

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Diabetes Mellitus, Type 1/metabolism; Insulin/analogs & derivatives; Insulin/metabolism; Monocytes/metabolism; Adult; Cell Line; Cross-Over Studies; Diabetes Mellitus, Type 1/blood; Down-Regulation; Eating; Female; Humans; Insulin/therapeutic use; Insulin Lispro; Lymphocytes/metabolism; Male; Middle Aged; Receptor, Insulin/drug effects; Receptor, Insulin/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / Diabetes Mellitus, Type 1 / Insulin Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Endocrinol Metab Year: 1996 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links